NYSE:BSX

Boston Scientific Price Target, Predictions & Analyst Ratings

$44.37
-0.53 (-1.18 %)
(As of 09/17/2021 12:00 AM ET)
Add
Compare
Today's Range
$43.92
$44.71
50-Day Range
$41.23
$45.88
52-Week Range
$32.99
$46.28
Volume7.70 million shs
Average Volume7.85 million shs
Market Capitalization$63.18 billion
P/E Ratio134.46
Dividend YieldN/A
Beta0.88

Boston Scientific (NYSE:BSX) Price Target and Consensus Rating

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Analyst Rating Consensus

Buy
Based on 13 Analyst Ratings

Analyst Price Target Consensus

$49.13

High PT$53.00
Average PT$49.13
Low PT$42.74
TypeCurrent
9/18/20 to 9/18/21
1 Month Ago
8/19/20 to 8/19/21
3 Months Ago
6/20/20 to 6/20/21
1 Year Ago
9/19/19 to 9/18/20
Consensus Rating
Buy
Buy
Buy
Buy
Strong Buy
1 Strong Buy rating(s)
1 Strong Buy rating(s)
1 Strong Buy rating(s)
3 Strong Buy rating(s)
Buy
10 Buy rating(s)
11 Buy rating(s)
13 Buy rating(s)
19 Buy rating(s)
Hold
2 Hold rating(s)
3 Hold rating(s)
5 Hold rating(s)
3 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$49.13$48.91$47.17$45.00
Price Target Upside10.74% Upside14.91% Upside15.49% Upside17.65% Upside
Get Boston Scientific Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for BSX and its competitors with MarketBeat's FREE daily newsletter.


Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

Average Share Price and Price Target by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Boston Scientific (NYSE:BSX) vs. Its Competitors

TypeBoston ScientificMedical CompaniesS&P 500
Consensus Rating Score
2.92
2.73
2.56
Consensus RatingBuyBuyBuy
Price Target Upside122.67% Upside8.34% Upside
News Sentiment RatingNeutral News
Neutral News
Neutral News
MarketBeat
Community Rating
Outperform Votes
910
70.49%
Underperform Votes
381
29.51%
Avg. Outperform Votes
178
67.17%
Avg. Underperform Votes
87
32.83%
Avg. Outperform Votes
829
69.55%
Avg. Underperform Votes
363
30.45%

Boston Scientific (NYSE:BSX) Analyst Ratings History

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
7/28/2021Credit Suisse Group
Boost Price TargetOutperform$50.00 ➝ $52.00+14.26%
7/28/2021Raymond James
Boost Price TargetStrong-Buy$50.00 ➝ $53.00+16.46%
7/28/2021Morgan Stanley
Boost Price TargetOverweight$51.00 ➝ $53.00+16.46%
7/15/2021Needham & Company LLC
Set Price TargetHold$42.74
6/7/2021Argus
Boost Price TargetBuy$45.00 ➝ $50.00+18.96%
5/24/2021Barclays
Initiated CoverageOverweight$51.00+19.16%
4/29/2021Truist
Boost Price Target$42.00 ➝ $50.00+13.38%
4/29/2021Canaccord Genuity
Boost Price TargetBuy$44.00 ➝ $49.00+10.76%
4/29/2021Wells Fargo & Company
Boost Price TargetIn-Line ➝ Overweight$42.00 ➝ $50.00+13.02%
4/29/2021Deutsche Bank Aktiengesellschaft
Boost Price TargetHold$39.00 ➝ $45.00+1.72%
4/15/2021Atlantic Securities
Initiated CoverageOverweight$52.00+31.08%
2/3/2021Piper Sandler
Boost Price TargetIn-Line ➝ Overweight$46.00 ➝ $48.00+28.00%
12/15/2020The Goldman Sachs Group
DowngradeConviction-Buy ➝ Buy
12/8/2020BTIG Research
Reiterated RatingBuy
11/18/2020Smith Barney Citigroup
Lower Price Target$46.00 ➝ $43.00+22.75%
9/11/2020Wolfe Research
Initiated CoverageMarket Perform$46.00+12.28%
7/30/2020Stifel Nicolaus
Rick Wise
Boost Price TargetBuy$45.00 ➝ $47.00+21.17%
7/30/2020Jefferies Financial Group
Boost Price TargetBuy$43.00 ➝ $46.00+19.70%
7/30/2020Citigroup
Boost Price TargetBuy$44.00 ➝ $46.00+15.55%
7/30/2020SVB Leerink
D. Antalffy
Boost Price TargetMarket Perform$40.00 ➝ $43.00+8.01%
7/29/2020Oppenheimer
Boost Price TargetMarket Perform$41.00 ➝ $43.00+8.01%
4/30/2020CSFB
Boost Price TargetOutperform$42.00 ➝ $43.00+14.73%
4/30/2020UBS Group
Lower Price TargetBuy$50.00 ➝ $45.00+21.46%
4/23/2020SunTrust Banks
Lower Price TargetBuy$28.00 ➝ $25.00-31.79%
3/23/2020Stephens
Chris Cooley
Lower Price TargetOverweight$48.00 ➝ $35.00+40.28%
3/9/2020Cfra
UpgradeBuy ➝ Strong-Buy$50.00 ➝ $47.00+36.47%
1/15/2020Cowen
Josh Jennings
Reiterated RatingBuy$52.00+22.15%
12/20/2019JPMorgan Chase & Co.
Boost Price TargetOverweight$50.00 ➝ $55.00+19.93%
10/25/2019Guggenheim
Christopher Pasquale
Set Price TargetBuy$53.00+27.31%
7/24/2019Piper Jaffray Companies
Matthew O'Brien
Set Price TargetBuy$50.00+18.82%
5/13/2019Evercore ISI
UpgradeIn-Line ➝ Outperform$36.20-1.04%
10/15/2018Royal Bank of Canada
Boost Price TargetTop Pick$42.00+15.10%
(Data available from 9/18/2016 forward. View 10+ years of historical ratings with our analyst ratings screener.)
speech bubbles
speech bubbles











Boston Scientific (NYSE:BSX) Analyst Ratings Frequently Asked Questions

What is Boston Scientific's consensus rating and price target?

According to the issued ratings of 13 analysts in the last year, the consensus rating for Boston Scientific stock is Buy based on the current 2 hold ratings, 10 buy ratings and 1 strong buy rating for BSX. The average twelve-month price target for Boston Scientific is $49.13 with a high price target of $53.00 and a low price target of $42.74. Learn more on BSX's analyst rating history

Do Wall Street analysts like Boston Scientific more than its competitors?

Analysts like Boston Scientific stock more than the stock of other Medical companies. The consensus rating score for Boston Scientific is 2.92 while the average consensus rating score for medical companies is 2.73. Learn more on how BSX compares to other companies

Do MarketBeat users like Boston Scientific more than its competitors?

MarketBeat users like Boston Scientific stock more than the stock of other Medical companies. 70.49% of MarketBeat users gave Boston Scientific an outperform vote while medical companies recieve an average of 67.17% outperform votes by MarketBeat users.

Does Boston Scientific's stock price have much upside?

According to analysts, Boston Scientific's stock has a predicted upside of 14.81% based on their 12-month price targets.

What analysts cover Boston Scientific?

Boston Scientific has been rated by Credit Suisse Group, Morgan Stanley, Needham & Company LLC, and Raymond James in the past 90 days.

This page was last updated on 9/18/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.